TOZ-CL06: A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients with Parkinson's Disease Experiencing End of Dose Wearing-Off

Grants and Contracts Details

StatusFinished
Effective start/end date5/12/174/2/18

Funding

  • Biotie Therapeutics Incorporated: $9,003.00